Pregnancy rate with clomiphen citrate and letrozole

Comparison of the pregnancy rate with clomiphen citrate and letrozole in women with poly-cystic ovarian syndrome

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20180602039952N2

Enrollment

Registered

2018-10-26

Start date

2018-03-21

Completion date

Unknown

Last updated

2019-01-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Polycystic ovarian syndrome. Polycystic ovarian syndrome

Interventions

Intervention 1: Intervention group 1:Receiving 100 mg clomiphen citrate orally on days 3-5 of the mensturation cycle. Intervention 2: Intervention group 2:Receiving 10 mg letrozole orally on days 3-5

Eligibility

Sex/Gender

Female

Age

18 Years to 40 Years

Inclusion criteria

Inclusion criteria: One-year infertility Normal semen analysis in the husband

Exclusion criteria

Exclusion criteria: Thyroid dysfunction Fallopian tube or uterine cavity abnormalities

Design outcomes

Primary

Measure	Time frame
Pregnancy rate. Timepoint: 1 month after giving the drugs. Method of measurement: By measuring the serum level of B-HCG using DiaPlus B-HCG STAT kit.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactFarahnaz Farzaneh

Zahedan University of Medical Sciences

f.farzaneh@zaums.ac.ir+98 54 3329 5744

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026